Project Grant R61HL169336

Award Date 9/1/24
Completion Date 8/31/25
Dollars Obligated $792K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding a randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing adherence to physical activity recommendations among patients with heart failure with preserved ejection fraction (HFPEF). The 5-year, $809,029 award will support a 3-arm trial to assess whether interventions using...
This Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) is for $940,798 and will be conducted from Aug 2024 to Apr 2029. The project aims to create a stepped care model to help under-resourced cardiovascular disease patients maintain improvements in health behaviors, such as weight management, physical activity, and medication adherence, after completing cardiac rehabilitation. The study will utilize a Sequential, Multiple Assignment,...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will provide $374,592 to the University of Rochester to conduct a research study on electronically-delivered home rehabilitation programs for patients who have experienced acute pulmonary embolism. The study aims to evaluate whether a prescriptive exercise program with heart rate monitoring is more effective than regular electronic contact in reducing post-pulmonary embolism...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,970,848 to The Children's Hospital of Philadelphia to evaluate the efficacy of a home-based, digital intervention to increase physical activity and improve physical fitness outcomes in youth with the Fontan circulation, a complex congenital heart condition. The project aims to: 1) determine if the digital intervention increases physical activity levels, 2) assess...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is focused on testing the effectiveness and implementation of a home-based exercise intervention for individuals with an implantable cardioverter defibrillator (ICD). The primary goal is to determine if the Exercise-ICD (E-ICD) intervention can increase physical activity and improve related health outcomes in this patient population. The $728,781 award to the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $321,363 to Nucleusrx, Inc. to develop and test a virtual care platform and remote intervention tool targeting post-acute care heart failure (HF) patients. The goal is to create a solution that enables healthcare providers to implement a safe discharge transition plan from hospital to home, while allowing rapid optimization of...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $452,181 to develop and test an 8-week exercise-based frailty intervention called XFIT for lung transplant candidates. The goal is to improve physical function and reduce frailty in this population at high risk for disability and mortality. The award includes sub-grants to Columbia University ($352,181) and the University of Pennsylvania ($100,000) to serve as study...
This Project Grant award of $2,256,023.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development and evaluation of a mobile app-based intervention to improve blood pressure medication adherence among Medicaid enrollees. The "Mobile Cued Adherence Therapy (MCAT)" intervention aims to leverage incentives and habit formation strategies to encourage consistent blood pressure medication usage, which is critical for managing...
This $625,835 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to optimize aerobic fitness and functional response to exercise in older adults. The grant aims to test the efficacy of a combined high-intensity interval training (HIIT) and high-intensity resistance training (HIRT) approach to improve peak oxygen uptake (VO2peak) and physical function in patients eligible for cardiac rehabilitation, compared to standard...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,208,196 to Pip Care, Inc. to develop and evaluate a novel digital health platform with a virtual health coach for improving perioperative patient outcomes and care coordination. The key products and services to be delivered under this award include: Expanding the Pip platform to develop new clinical pathway modules for additional comorbidities, surgery types, and...

This federal Project Grant award of $792,235 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development and execution of a randomized clinical trial to evaluate the effectiveness of a commercially available fitness mHealth app (Rehabbing with Peloton) for improving physical activity among individuals recovering from transcatheter aortic valve replacement (TAVR).

The key products and services to be delivered under this grant include: 1) Preparing for and launching a randomized controlled trial comparing the Rehabbing with Peloton intervention to an attention control group in TAVR patients, 2) Assessing the intervention's impact on physical activity levels and secondary outcomes like functional capacity and quality of life, and 3) Evaluating the implementation of the Rehabbing with Peloton program using the RE-AIM framework to inform future scalability. Sub-awards to Beth Israel Deaconess Medical Center and Denver Health and Hospital Authority will support various aspects of the research, clinical, and implementation activities.

Generated 7/1/25, 3:21 AM